Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine

Greta Scapinello, Marco Pizzi, Stefania Vio, Mitja Nabergoj, Andrea Visentin, Annalisa Martines, Laura Bonaldi, Livio Trentin, Gianpietro Semenzato, Francesco Piazza

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2001-2003
Number of pages3
JournalAnnals of Hematology
Volume97
Issue number10
DOIs
Publication statusPublished - Oct 2018

Keywords

  • Abnormal Karyotype
  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Bendamustine Hydrochloride/administration & dosage
  • Cell Lineage
  • Chromosomes, Human, Pair 12
  • Chromosomes, Human, Pair 14/genetics
  • Chromosomes, Human, Pair 8/genetics
  • Disease Progression
  • Female
  • Genes, Immunoglobulin
  • Genes, myc
  • Humans
  • Immunoglobulin Heavy Chains/genetics
  • Lymphocytes/pathology
  • Lymphoma, B-Cell, Marginal Zone/drug therapy
  • Middle Aged
  • Remission Induction
  • Rituximab/administration & dosage
  • Splenic Neoplasms/drug therapy
  • Translocation, Genetic
  • Trisomy

Cite this